Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo

被引:14
|
作者
Lee, M. K. [1 ]
Tong, W. M. [2 ]
Wang, Z. Q. [3 ,4 ]
Sabapathy, K. [1 ,5 ,6 ]
机构
[1] Natl Canc Ctr, Mol Carcinogenesis Lab, Div Cellular & Mol Res, Humphrey Oei Inst Canc Res, Singapore 169610, Singapore
[2] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing 100037, Peoples R China
[3] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany
[4] Friedrich Schiller Univ, Biol & Pharm Fac, D-07745 Jena, Germany
[5] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore
[6] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore
来源
CELL DEATH AND DIFFERENTIATION | 2011年 / 18卷 / 02期
基金
英国医学研究理事会;
关键词
ER-stress; p53; phosphorylation; protein stability; S312; EMBRYONIC STEM-CELLS; DNA-DAMAGE; TUMOR-SUPPRESSOR; POINT MUTATION; MOUSE MODELS; MDM2; DEGRADATION; APOPTOSIS; MICE; TRANSCRIPTION;
D O I
10.1038/cdd.2010.90
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular stimulation results in phosphorylation of the tumor suppressor p53 on multiple residues, though the functional relevance is not always clear. It is noteworthy that the serine (S) 315 residue is unique, as it has been suggested to be phosphorylated not only by genotoxic signals, but also during cell-cycle progression and by endoplasmic-reticulum stress. However, in vitro data have been conflicting as phosphorylation at this site was shown to both positively and negatively regulate p53 functions. We have thus generated knock-in mice expressing an unphosphorylable S312 (equivalent to human S315), by substitution with an alanine (A) residue, to clarify the conflicting observations and to evaluate its functional relevance in vivo. Born at Mendelian ratios, the p53(S312A/S312A) mice show no anomalies during development and adulthood. p53 activation, stability, localization and ability to induce apoptosis, cell-cycle arrest and prevent centrosome amplification are not compromised in p53(S312A/S312A) cells. p53(S312A/S312A) mice are unable to rescue mdm2(-/-) lethality, and tumorigenesis - both spontaneous and irradiation/oncogene-induced - is not accentuated. Taken together, the results show that the S312 phosphorylation site is not in itself necessary for efficient p53 function, and advocates the possibility that it is neither relevant in the mouse context nor important for p53 functions in vivo. Cell Death and Differentiation (2011) 18, 214-221; doi: 10.1038/cdd.2010.90; published online 30 July 2010
引用
收藏
页码:214 / 221
页数:8
相关论文
共 50 条
  • [1] Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo
    M K Lee
    W M Tong
    Z Q Wang
    K Sabapathy
    Cell Death & Differentiation, 2011, 18 : 214 - 221
  • [2] Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53
    Sugikawa, E
    Yazaki, N
    Tsunoda, S
    Nakanishi, N
    Ohashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 256 - 263
  • [3] In the right place at the right time Analysis of p53 serine 312 phosphorylation in vivo
    Slee, Elizabeth A.
    Lu, Xin
    CELL CYCLE, 2011, 10 (09) : 1345 - 1346
  • [4] SERINE MUTANTS OF HUMAN P53 IN THE ACTIVATION DOMAIN ARE WILD-TYPE FOR TRANSFORMATION SUPPRESSION AND TRANSACTIVATION FUNCTIONS
    UNGER, T
    SCHEFFNER, M
    YEE, CL
    HOWLEY, PM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 184 - 184
  • [5] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    Palacios, G.
    Moll, U. M.
    ONCOGENE, 2006, 25 (45) : 6133 - 6139
  • [6] Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo
    G Palacios
    U M Moll
    Oncogene, 2006, 25 : 6133 - 6139
  • [7] Disruption of functions of wild-type p53 by hetero-oligomerization
    Deb, D
    Chakraborti, AS
    Lányi, A
    Troyer, DA
    Deb, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (03) : 413 - 422
  • [8] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [9] THE CARBOXY-TERMINAL SERINE-392 PHOSPHORYLATION SITE OF HUMAN P53 IS NOT REQUIRED FOR WILD-TYPE ACTIVITIES
    FISCELLA, M
    ZAMBRANO, N
    ULLRICH, SJ
    UNGER, T
    LIN, D
    CHO, B
    MERCER, WE
    ANDERSON, CW
    APPELLA, E
    ONCOGENE, 1994, 9 (11) : 3249 - 3257
  • [10] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73